BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 14579280)

  • 1. Endothelial expression of PD-L1 and PD-L2 down-regulates CD8+ T cell activation and cytolysis.
    Rodig N; Ryan T; Allen JA; Pang H; Grabie N; Chernova T; Greenfield EA; Liang SC; Sharpe AH; Lichtman AH; Freeman GJ
    Eur J Immunol; 2003 Nov; 33(11):3117-26. PubMed ID: 14579280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PD-L1 partially protects renal tubular epithelial cells from the attack of CD8+ cytotoxic T cells.
    Waeckerle-Men Y; Starke A; Wüthrich RP
    Nephrol Dial Transplant; 2007 Jun; 22(6):1527-36. PubMed ID: 17339272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PD-L2 is a second ligand for PD-1 and inhibits T cell activation.
    Latchman Y; Wood CR; Chernova T; Chaudhary D; Borde M; Chernova I; Iwai Y; Long AJ; Brown JA; Nunes R; Greenfield EA; Bourque K; Boussiotis VA; Carter LL; Carreno BM; Malenkovich N; Nishimura H; Okazaki T; Honjo T; Sharpe AH; Freeman GJ
    Nat Immunol; 2001 Mar; 2(3):261-8. PubMed ID: 11224527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells.
    Latchman YE; Liang SC; Wu Y; Chernova T; Sobel RA; Klemm M; Kuchroo VK; Freeman GJ; Sharpe AH
    Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10691-6. PubMed ID: 15249675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.
    Schreiner B; Mitsdoerffer M; Kieseier BC; Chen L; Hartung HP; Weller M; Wiendl H
    J Neuroimmunol; 2004 Oct; 155(1-2):172-82. PubMed ID: 15342209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells.
    Loke P; Allison JP
    Proc Natl Acad Sci U S A; 2003 Apr; 100(9):5336-41. PubMed ID: 12697896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Keratinocyte-associated B7-H1 directly regulates cutaneous effector CD8+ T cell responses.
    Ritprajak P; Hashiguchi M; Tsushima F; Chalermsarp N; Azuma M
    J Immunol; 2010 May; 184(9):4918-25. PubMed ID: 20363965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limited costimulatory molecule expression on renal tubular epithelial cells impairs T cell activation.
    Waeckerle-Men Y; Starke A; Wahl PR; Wüthrich RP
    Kidney Blood Press Res; 2007; 30(6):421-9. PubMed ID: 17975322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of programmed death 1 and its ligands in the liver of autoimmune hepatitis C57BL/6 mice.
    Cao J; Liu FX; Yu MX
    Chin Med J (Engl); 2009 Aug; 122(16):1941-6. PubMed ID: 19781375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B7-H1 on hepatocytes facilitates priming of specific CD8 T cells but limits the specific recall of primed responses.
    Wahl C; Bochtler P; Chen L; Schirmbeck R; Reimann J
    Gastroenterology; 2008 Sep; 135(3):980-8. PubMed ID: 18621049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The capacity of the natural ligands for CD28 to drive IL-4 expression in naïve and antigen-primed CD4+ and CD8+ T cells.
    Bian Y; Hiraoka S; Tomura M; Zhou XY; Yashiro-Ohtani Y; Mori Y; Shimizu J; Ono S; Dunussi-Joannopoulos K; Wolf S; Fujiwara H
    Int Immunol; 2005 Jan; 17(1):73-83. PubMed ID: 15569772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PD-L1 is expressed by human renal tubular epithelial cells and suppresses T cell cytokine synthesis.
    Ding H; Wu X; Gao W
    Clin Immunol; 2005 May; 115(2):184-91. PubMed ID: 15885642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual control of antitumor CD8 T cells through the programmed death-1/programmed death-ligand 1 pathway and immunosuppressive CD4 T cells: regulation and counterregulation.
    Currie AJ; Prosser A; McDonnell A; Cleaver AL; Robinson BW; Freeman GJ; van der Most RG
    J Immunol; 2009 Dec; 183(12):7898-908. PubMed ID: 20007574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mouse Sertoli cells display phenotypical and functional traits of antigen-presenting cells in response to interferon gamma.
    Dal Secco V; Riccioli A; Padula F; Ziparo E; Filippini A
    Biol Reprod; 2008 Feb; 78(2):234-42. PubMed ID: 17989360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of T-cell responses by hepatic stellate cells via B7-H1-mediated T-cell apoptosis in mice.
    Yu MC; Chen CH; Liang X; Wang L; Gandhi CR; Fung JJ; Lu L; Qian S
    Hepatology; 2004 Dec; 40(6):1312-21. PubMed ID: 15565659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time courses of B7 family molecules expressed on activated T-cells and their biological significance.
    Sun ZW; Qiu YH; Shi YJ; Tao R; Chen J; Ge Y; Hu YM; Ma HB; Shi Q; Zhang XG
    Cell Immunol; 2005; 236(1-2):146-53. PubMed ID: 16165113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-cell suppression by programmed cell death 1 ligand 1 on retinal pigment epithelium during inflammatory conditions.
    Sugita S; Usui Y; Horie S; Futagami Y; Aburatani H; Okazaki T; Honjo T; Takeuchi M; Mochizuki M
    Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2862-70. PubMed ID: 19182257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human decidual stromal cells suppress cytokine secretion by allogenic CD4+ T cells via PD-1 ligand interactions.
    Nagamatsu T; Schust DJ; Sugimoto J; Barrier BF
    Hum Reprod; 2009 Dec; 24(12):3160-71. PubMed ID: 19729380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of enhanced antigen presentation by B cells activated with anti-mu plus interferon-gamma: role of B7-2 in the activation of naive and memory CD4+ T cells.
    Morokata T; Kato T; Igarashi O; Nariuchi H
    Eur J Immunol; 1995 Jul; 25(7):1992-8. PubMed ID: 7542599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced antigen concentration and costimulatory blockade increase IFN-gamma secretion in naive CD8+ T cells.
    Hall HT; Petrovic J; Höglund P
    Eur J Immunol; 2004 Nov; 34(11):3091-101. PubMed ID: 15384046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.